title: Multiple Myeloma--Better Drugs Ask for More Stringent Evaluations.
authors.affiliation: Department of Hematology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands.
authors.forename: Pieter
authors.initials: P
authors.lastname: Sonneveld
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003907:Dexamethasone / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy*; D009842:Oligopeptides / Q000008:administration & dosage*; D061988:Proteasome Inhibitors / Q000008:administration & dosage*; D013792:Thalidomide / Q000031:analogs & derivatives*
chemical_list: D020533:Angiogenesis Inhibitors; D009842:Oligopeptides; D061988:Proteasome Inhibitors; D013792:Thalidomide; D003907:Dexamethasone